ArticleInternational journal of women's health2025
Association Between Magnesium Intake and Migraine Among Pre and Postmenopausal Women: A Cross-Sectional Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary interventions and nutritional strategies for menopausal health: a mini review.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate whether menopausal status modifies the association between magnesium intake and migraine in women, hypothesizing that hormonal differences between pre-menopausal and post-menopausal women would result in differential responses to magnesium intake. Background: While magnesium's role in migraine management has gained attention, the relationship between magnesium intake and migraine across menopausal status remains poorly studied. This is the first study to compare this association between pre-menopausal and post-menopausal women specifically. Methods: This cross-sectional study analyzed 3,248 women from the National Health and Nutrition Examination Survey (1999-2004), which achieved interview response rates of 79-84%. Menopausal status was determined by self-report: pre-menopausal (n=1,412) or post-menopausal (n=1,836). The exposure variable was total magnesium intake (dietary plus supplements); the outcome was self-reported migraine. Covariates included age, race, education, income, body mass index, smoking, drinking, hypertension, diabetes, C-reactive protein, estimated glomerular filtration rate, and calcium intake. Non-linear relationships were examined using piecewise logistic regression. Results: Migraine prevalence was higher in pre-menopausal (31.3%) than post-menopausal women (15.6%). A significant non-linear relationship between magnesium intake and migraine was observed in pre-menopausal women, with odds of migraine decreasing by 36.0% per unit increase in magnesium intake below 325.41 mg/day (OR: 0.64, 95% CI: 0.42-0.98, P=0.042), with no significant association above the threshold. No significant association was found in post-menopausal women. Supplementary weighted analysis validated these findings. Conclusion: Menopausal status may modify the relationship between magnesium intake and migraine. Adequate magnesium intake may be beneficial for reducing migraine risk in pre-menopausal women. Given that over half of American adults fail to meet recommended magnesium intake, these findings have significant public health implications for targeted dietary interventions in reproductive-age women, though prospective validation is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.